Medical News

RSS

MH6 vaccine shows promise in treating meth addiction

Scientists at The Scripps Research Institute (TSRI) have performed successful tests of an experimental methamphetamine vaccine on rats. Vaccinated animals that received the drug were largely protected from typical signs of meth intoxication.

2 Nov 2012

Antipsychotic drugs associated with increased mortality among people with schizophrenia

Results of a Johns Hopkins study suggest that individuals with schizophrenia are significantly more likely to live longer if they take their antipsychotic drugs on schedule, avoid extremely high doses and also regularly see a mental health professional.

2 Nov 2012

Global wealth inequality threatens progress made in reducing child mortality, Save the Children report says

While progress has been made worldwide in reducing child mortality, the effects have been unequal across income groups, and wealth inequalities are at the highest level in 20 years and increasing, according to a report from Save the Children U.K., BBC News reports.

2 Nov 2012

NIH grant increases support of SDSU program that prepares students for doctoral and science careers

Funded by a $2.8 million grant from the National Institutes of Health and the National Institute of General Medical Sciences, the Initiative for Maximizing Student Development supports 30 students studying in the fields of biomedical and behavioral sciences.

2 Nov 2012

Study describes role of TFIIB protein in helping cells repair DNA damage

In a new study, University at Buffalo scientists describe the role that a protein called TFIIB plays in helping cells repair DNA damage, a critical function for preventing the growth of tumors.

2 Nov 2012

Insomnia and sleep apnoea turn us into major health service consumers

Insomnia and sleep apnoea are turning us into major health service consumers, causing us to be less productive at work, and may even lead to serious accidents.

2 Nov 2012

Janssen, Vertex to evaluate TMC435 and VX-135 in Phase 2 HCV study

Janssen Pharmaceuticals, Inc. today announced that it has entered into a non-exclusive collaboration with Vertex Pharmaceuticals Incorporated to evaluate in a Phase 2 study the safety and efficacy of an all-oral regimen for the treatment of hepatitis C (HCV).

2 Nov 2012

Longer looks: Searching for a dementia gene; The trouble with medical device patents; Blue dog Matheson's re-election quest

When it comes to preparing for a natural disaster like superstorm Sandy, hospitals drill for such evacuations and activate emergency command centers to manage any increase in patients. Still, events like superstorm Sandy are hard to prepare for. "It's been an unprecedented situation that has required an unprecedented response from the whole tri-state health care system," says Jim Mandler, assistant vice president for public affairs for Continnum Health Partners hospitals.

2 Nov 2012

FDA clears X-spine’s new Fortex and Certex system

X-spine, a global leader in the design and manufacture of devices for the treatment of spinal disease, today announced two new USFDA clearances for spinal systems: The Fortex CoCr Rod System and the Certex Cervico-thoracic Fixation System.

2 Nov 2012

New data: 4 in 5 children received recommended doses of DTP vaccine during infancy in 2011

Four in five children (83%) worldwide received the recommended three doses of diphtheria-tetanus-pertussis (DTP) vaccine during infancy in 2011, according to new data released in the Morbidity and Mortality Weekly Report and in the WHO Weekly Epidemiological Record (WER).

2 Nov 2012

Study identifies monoacylglycerol lipase as new therapeutic target to treat Alzheimer's

Research led by Chu Chen, PhD, Associate Professor of Neuroscience at LSU Health Sciences Center New Orleans, has identified an enzyme called Monoacylglycerol lipase (MAGL) as a new therapeutic target to treat or prevent Alzheimer's disease.

2 Nov 2012

TransTech Pharma to complete TTP054 Phase 2 trial on type 2 diabetes

TransTech Pharma, Inc., announced today that recruitment of patients for its recently initiated, multi-center Phase 2 clinical trial of TTP054 in type 2 diabetics, is exceeding expectations with initial top line results available in early 2013. The 90-day proof of concept study is being conducted in type 2 diabetics not well controlled with approved oral anti-diabetic agents.

2 Nov 2012

Roundup: Texas will keep Planned Parenthood Women's Health Program for now; Kids' autism covered in Wash. Medicaid; UnitedHealth selling S.C. Medicaid biz

Planned Parenthood will continue to receive funds from a joint Texas and federal program providing health care to low-income women, despite the state's promise to exclude its clinics by Nov. 1 because they are affiliated with abortion providers.

2 Nov 2012

Oskar gene emerged far earlier in insect evolution than previously believed

Harvard scientists have solved the long-standing mystery of how some insects form the germ cells - the cellular precursors to the eggs and sperm necessary for sexual reproduction - and the answer is shedding new light on the evolutionary origins of a gene that had long been thought to be critical to the process.

2 Nov 2012

Malarial drug shows promise in stopping breast cancer

A malarial drug is showing promise in stopping breast cancer before it starts, Mason researchers are discovering during a clinical trial.

2 Nov 2012

Apolipoprotein E plays a major role in maintaining arterial softness

Arterial stiffening has long been considered a major risk factor for cardiovascular disease. Keeping arteries soft and supple might reduce disease risk, but the mechanisms of how arteries stave off hardening has remained elusive.

2 Nov 2012

Inotek announces final data from trabodenoson Phase 2 trial on PAOG or ocular hypertension

Inotek Pharmaceuticals Corp., a leader in the development of innovative drug candidates to address significant diseases of the eye, today announced that final data from a Phase 2 clinical trial of trabodenoson, also known as INO-8875, in patients with primary open-angle glaucoma or ocular hypertension will be presented at the Ophthalmology Innovation Summit on Thursday, November 8, 2012 at the Chicago Marriott Downtown Magnificent Mile in Chicago, IL.

2 Nov 2012

High blood cholesterol far more common than previously recognized

High blood cholesterol, a serious hereditary disease, is far more common than previously recognised and not treated sufficiently.

2 Nov 2012

NJH researchers discover novel target for treatment of food allergies

Researchers at National Jewish Health have discovered a novel target for the treatment of food allergies. Erwin Gelfand, MD, and his colleagues report in the October 2012 issue of the Journal of Allergy and Clinical Immunology that levels of the enzyme Pim 1 kinase rise in the small intestines of peanut-allergic mice. Inhibiting activity of Pim 1 markedly reduced the allergic response to peanuts.

2 Nov 2012

Study explores impact of IL1β on brain function alterations associated with schizophrenia

There are a growing number of clues that immune and inflammatory mechanisms are important for the biology of schizophrenia. In a new study in Biological Psychiatry, Dr. Mar Fatjó-Vilas and colleagues explored the impact of the interleukin-1β gene (IL1β) on brain function alterations associated with schizophrenia.

2 Nov 2012

Medical News

MH6 vaccine shows promise in treating meth addiction

Antipsychotic drugs associated with increased mortality among people with schizophrenia

Global wealth inequality threatens progress made in reducing child mortality, Save the Children report says

NIH grant increases support of SDSU program that prepares students for doctoral and science careers

Study describes role of TFIIB protein in helping cells repair DNA damage

Insomnia and sleep apnoea turn us into major health service consumers

Janssen, Vertex to evaluate TMC435 and VX-135 in Phase 2 HCV study

Longer looks: Searching for a dementia gene; The trouble with medical device patents; Blue dog Matheson's re-election quest

FDA clears X-spine’s new Fortex and Certex system

New data: 4 in 5 children received recommended doses of DTP vaccine during infancy in 2011

Study identifies monoacylglycerol lipase as new therapeutic target to treat Alzheimer's

TransTech Pharma to complete TTP054 Phase 2 trial on type 2 diabetes

Roundup: Texas will keep Planned Parenthood Women's Health Program for now; Kids' autism covered in Wash. Medicaid; UnitedHealth selling S.C. Medicaid biz

Oskar gene emerged far earlier in insect evolution than previously believed

Malarial drug shows promise in stopping breast cancer

Apolipoprotein E plays a major role in maintaining arterial softness

Inotek announces final data from trabodenoson Phase 2 trial on PAOG or ocular hypertension

High blood cholesterol far more common than previously recognized

NJH researchers discover novel target for treatment of food allergies

Study explores impact of IL1β on brain function alterations associated with schizophrenia

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Latest News